INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 29 February 2016
Net Assets |
£189m |
Net Assets per share |
483p |
Share price |
425p |
Total value of unquoted investments |
£22m |
Total number of portfolio companies |
80 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
9.2 |
Amgen |
8.3 |
Gilead |
8.2 |
Biogen |
8.1 |
Regeneron |
6.0 |
Alexion |
4.7 |
Medivation |
4.3 |
Incyte |
3.1 |
Genmab |
3.1 |
Ophthotech |
2.8 |
|
----------- |
Total |
57.8 |
Portfolio Profitability |
% NAV |
Profitable |
67 |
Turning Profitable 2016 |
5 |
Unprofitable |
28 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
84 |
Europe & UK |
16 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
88 |
Unquoted |
12 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
29 MARCH 2016